Risk Factors for Adverse Drug Events in Nursing Home Residents/Movement Disorder Caused by Cough Syrup/Visual Disturbance with Mirtazapin/Acute Renal Failure Associated with Celecoxib/Rhabdomyolysis with Cerivastatin/Liver Toxicity with an Herbal Preparation/Sulfamethoxazole/Trimethoprim-Induced Toxic Epidermal Necrolysis
Restricted accessResearch articleFirst published online September, 2001
Risk Factors for Adverse Drug Events in Nursing Home Residents/Movement Disorder Caused by Cough Syrup/Visual Disturbance with Mirtazapin/Acute Renal Failure Associated with Celecoxib/Rhabdomyolysis with Cerivastatin/Liver Toxicity with an Herbal Preparation/Sulfamethoxazole/Trimethoprim-Induced Toxic Epidermal Necrolysis
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers. Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices in cooperation with the FDA's medWatch Program and Temple University School of Pharmacy. ISMP is a FDA medWatch partner.
Get full access to this article
View all access options for this article.
References
1.
FieldT.S., GurwitzJ.H., AvornJ.Risk factors for adverse drug events among nursing home residents. Arch Intern Med.2001; 161: 1629–34.
2.
NairnS.J., DiazJ.E.Cold-syrup induced movement disorder. Pediatr Emerg Care.2001; 17: 191–2.
